老年人心力衰竭:流行病学,机制和管理
Rudolf A de Boer1, Mahmoud Abdellatif2, Johann Bauersachs3
1Department of Cardiology, Thorax Center, Cardiovascular Institute, Erasmus MC, Dr. Molewaterplein 40, Rotterdam 3015GD, The Netherlands.
European heart journal
|February 27, 2026
概括
70岁以后,由于影响心脏的生物衰老过程,心力衰竭 (HF) 的风险显著增加. 目前的治疗方法可能受到老年患者的并发症和虚弱的限制.
科学领域:
- 心脏病学 心脏病学
- 老年学是指老年学的学科.
- 分子生物学分子生物学
背景情况:
- 心力衰竭 (HF) 不成比例地影响老年人,70岁以后的发病率急剧上升.
- 生物衰老涉及心肌变化,如受损的自,线粒体功能障碍和炎症,增加HF风险.
- 性差异存在于HF表型中,女性易患HF,具有保存的喷射分数,男性易患HF,具有减少的喷射分数.
研究的目的:
- 审查生物衰老对心力衰竭病变的影响.
- 讨论老年患者治疗高血压的挑战和考虑因素.
- 突出需要量身定制的治疗策略和先进的护理规划.
主要方法:
- 文献综述和综合关于衰老和心力衰竭的当前研究.
- 对影响心肌的与年龄相关的病理生理机制的分析.
- 讨论指南推的疗法,并发病症和老年人的器械干预措施.
主要成果:
- 衰老会损害心脏能量稳定,促进细胞损失,并通过现有疗法未针对的机制增加心脏病风险.
- 伴随性疾病,虚弱和特定年龄的生理变化 (例如低血压) 往往限制了老年人全剂量指南推的医学治疗.
- 由于存在竞争的非心脏风险,医疗器械的风险效益比需要仔细评估.
结论:
- 与衰老相关的机制是导致心力衰竭的关键因素,但目前的标准治疗方法并没有解决这些问题.
- 在老年人中治疗HF需要仔细考虑并发症和个体患者的因素,往往需要剂量调整或替代策略.
- 对心力衰竭的老年患者来说,及时讨论高级护理规划和终身决策是必不可少的.
相关概念视频
Heart Failure I: Introduction
1.0K
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.0K
Pathophysiology of Heart Failure
4.2K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.2K
Heart Failure VII: Nursing Interventions
599
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
599
Heart Failure V: Medical Management
428
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
428
Heart Failure IV: Classification and Diagnostic Evaluation
486
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
486
Heart Failure II: Pathophysiology
1.1K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K


